National Association of Testing Authorities, Australia
Scope of Accreditation
Prince of Wales Hospital
Site
Prince of Wales Hospital
University Pathology Service
Accreditation No.
14149
Site No.
14142
Date of Accreditation
28 Apr 1999
Address
30-32 Ngan Shing Street, SHATIN N.T.
0
Hong Kong
Contact
Prof Ka Fai To
P: 85 226323335
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
Department of Anatomical and Cellular Pathology
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Vaginal smears; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy | Gluteraldehyde tissue | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen sections of fresh tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 2 mortuary |
| Anatomical pathology - Tissue pathology - Skeletal muscle enzyme histochemistry | Frozen sections of skeletal muscle | Detection of muscle enzyme targets |
| Cytogenetics - Detection of defined, unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Blood; Bone marrow | Cytogenetic analysis and reporting |
| Tissues | Cytogenetic analysis and reporting | |
| Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalities | Amniotic fluid; Blood; Bone marrow; Chorionic villus tissue | Cytogenetic analysis and reporting |
| Cytogenetics - Karyotype detection of unbalanced abnormalities | Amniotic fluid; Chorionic villus tissue | Pathogenic copy number changes |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Cytochemical indicators; Morphology | ||
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Feto-maternal haemorrhage (FMH) estimation |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Reticulocytes |
| Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Blood; Plasma | Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-thrombin III; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor VIIIc inhibitor; Factor X; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | |
| D-dimer | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Pericardial fluid; Peritoneal fluid; Pleural fluid | Assess cell numbers | |
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Red blood cell phenotyping |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD34 |
| Paroxysmal nocturnal haemoglobinuria (PNH) surface markers | ||
| Blood; Bone marrow | CD10; CD117; CD13; CD14; CD15; CD16; CD19; CD1a; CD2; CD20; CD22; CD235a; CD28; CD3; CD33; CD34; CD40; CD41; CD42b; CD45; CD5; CD54; CD59; CD61; CD66abce; CD79a; CD8; GlycoA; HLA-DR antigen; Immunoglobulin M (IgM); Myeloperoxidase; Terminal deoxynucleotidyl transferase (TdT) | |
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells | Haemopoietic progenitor cells | Clonogenic assays (culture) of harvested bone marrow/peripheral blood progenitor cells/cord blood stem cells; Enumeration of CD34+ cells; Processing; Storage (includes freezing/thawing); Total leucocyte number |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Morphology; Motility; Sperm number |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Liquid based cytology specimens | Human papilloma virus (HPV) |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Microfilaria |
| Malaria | ||
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Haemochromatosis; Methylenetetrahydrofolate reductase (MTHFR); Prothrombin variant |
| Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues | Blood borne tumours; Solid tumours | |
| Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours | |
| Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening) | Amniotic fluid; Chorionic villus | Trisomy 13, trisomy 18, trisomy 21 |
Department of Chemical Pathology – Biomedical Mass Spectrometry Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Amphetamines; Barbiturates; Lysergic acid diethylamide (LSD, lysergide); Methadone; Methadone metabolites; Oxycodone; Phencyclidine; Propoxyphene |
| Chemical pathology - Biogenic amines | Urine | 5-Hydroxyindoleacetic acid (5-HIAA); Vanillylmandelic acid (VMA) |
| 3-Methoxytyramine; Adrenaline; Dopamine; Metanephrine; Noradrenaline; Normetanephrine | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Everolimus; Sirolimus; Tacrolimus |
| Plasma | Mycophenolic acid | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Aldosterone; Renin |
| Serum | Dehydroepiandrosterone sulfate (DHEAS) | |
| 17α-Hydroxyprogesterone; Androstenedione; Testosterone | ||
| Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Urine | Aldosterone; Cortisol | |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Urine | Oxalate |
| Chemical pathology - Quantitation of vitamins | Serum | 25-Hydroxyvitamin D |
Department of Chemical Pathology – Clinical Immunology Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Alkaline phosphatase (ALP) isoenzymes |
| Chemical pathology - Trace element analysis | Blood | Arsenic; Cadmium; Chromium; Cobalt; Lead; Manganese; Mercury; Zinc |
| Serum | Aluminium; Copper; Selenium; Zinc | |
| Urine | Arsenic; Cadmium; Chromium; Cobalt; Copper; Iodine; Lead; Manganese; Mercury; Nickel; Zinc | |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-extractable nuclear antigen antibodies (ENA) |
| Anti-skin antibodies; Anti-striated muscle antibodies | ||
| Anti-cardiolipin antibodies (ACA); Anti-double stranded DNA antibodies (dsDNA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-intrinsic factor antibodies (IF); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3) | ||
| Anti-double stranded DNA antibodies (dsDNA); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-parietal cell antibodies; Anti-smooth muscle antibodies (SMA) | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Cat dander; Dog dander |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg white |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Codfish |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cow milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Peanut; Soy bean; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | American cockroach; German cockroach |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides microceras house dust mite; Dermatophagoides pteronyssinus house dust mite; Euroglyphus mayne house dust mite |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum; Urine | Detection and amount of paraproteins |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
Department of Chemical Pathology – Laboratory Automated System Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma | Carbamazepine; Paracetamol (acetaminophen); Phenobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Valproate (valproic acid, epilim) |
| Serum | Digoxin | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); Thyroglobulin |
| β2-Microglobulin (B2M) | ||
| CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); α-Fetoprotein (AFP) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Cortisol; Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Testosterone |
| Adrenocorticotropic hormone (ACTH); C-peptide; Calcitonin; Growth hormone; Insulin | ||
| Chemical pathology - Further investigation of cardiac function | Serum | Troponin T |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma | Caeruloplasmin; Haptoglobins; α1-Antitrypsin |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Other body fluids | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatinine; Glucose; Lactate dehydrogenase (LDH); Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea | |
| Plasma | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Cholinesterase | ||
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Iron studies | Plasma | Iron; Total iron-binding capacity (TIBC) |
| Serum | Ferritin | |
| Chemical pathology - Quantitation of vitamins | Serum | Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
| Immunopathology - Quantitation of complement proteins | Plasma | Complement components C3 and C4 |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Serum | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Department of Chemical Pathology – Molecular Biology and Inherited Metabolic Diseases Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Calculi | Ammonium; Calcium; Cysteine; Oxalate; Phosphate |
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Cerebrospinal fluid (CSF); Serum | Transferrin isoforms |
| Serum | Very long chain fatty acids (vLCFA) | |
| Acylcarnitine profile; Carnitines | ||
| Urine | Organic acids | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Other body fluids; Urine | pH |
| Chemical pathology - Investigation of malabsorption | Urine | Sulfite |
| Fructose; Galactose; Glucose; Lactose | ||
| Reducing substances | ||
| Glucose; Ketones | ||
| Chemical pathology - Investigation of porphyria | Urine | Porphobilinogen (PBG); δ-Aminolevulinic acid (δ-ALA) |
| Porphyrins - Total | ||
| Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism | Cerebrospinal fluid (CSF); Plasma; Urine | Creatine and guanidinoacetate; Creatinine |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Cerebrospinal fluid (CSF); Plasma; Urine | Amino acids |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | 5α-Reductase; Alpers syndrome; Congenital adrenal hyperplasia; Dystonia; Kennedy's disease (spinal and bulbar muscular atrophy); Maturity onset diabetes of the young (MODY); Multiple endocrine neoplasia; Nucleic acid analysis for specific variants; Paragangliomas; Spinal muscular atrophy; Thyroid hormone receptor (THRB gene mutation); Torsional dystonia (TOR1A) common mutation screen; Von Hippel Lindau disease; Wilsons disease; X-linked adrenoleukodystrophy |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood | Nucleic acid analysis for specific variants |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood | Nucleic acid analysis for unknown variants |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Blood | Nucleic acid analysis for unknown variants |
| Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood | Polycystic kidney disease |
Department of Chemical Pathology – Urgent Laboratory and Reception Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood | Cyanide |
| Serum | Methanol | |
| Urine | Paraquat | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Amitriptyline; Clomipramine; Desipramine; Doxepin; Imipramine; Methotrexate; Nortriptyline; Trimipramine |
| Lithium | ||
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Serum; Urine | Osmolality |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Blood | β-Hydroxybutyrate |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Cryoglobulins |
Department of Microbiology
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Amikacin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Vancomycin |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Fluids; Synovial fluid | Bacteria; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility |
| Biopsy specimens; Post-operative wounds; Pus; Wound swabs | Bacteria; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Blood | Pathogenic identification and antibiotic susceptibility | |
| Cerebrospinal fluid (CSF) | Bacteria; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Cervical swabs; Genital swabs; Urethra; Vaginal swabs | Bacteria; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Ear swabs; Eye swabs; Superficial sites | Bacteria; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Faeces | Clostridium difficile glutamate dehydrogenase | |
| Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | ||
| Gastric biopsy | Helicobacter pylori | |
| Nasal swabs; Throat swabs | Pathogenic identification and antibiotic susceptibility | |
| Nasopharyngeal swabs; Respiratory specimens; Sputum | Epithelial cells; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Ocular specimens | Bacteria; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Rectal swabs; Vaginal swabs | Streptococcus group B screening | |
| Tissues | Bacteria; Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Urine | Legionella antigen | |
| Bacteria; Casts; Crystals; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | ||
| Streptococcus pneumoniae antigen | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Groin swabs; Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA) |
| Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) | ||
| Faeces; Rectal swabs | Carbapenem resistant Enterobacteriaceae (CRE); Vancomycin resistant Enterococci (VRE) | |
| Infection control swabs | Carbapenem resistant Acinetobacter (CRAB) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Bronchial washings; Bronchoalveolar lavage; Nasopharyngeal aspirate; Sputum | Chlamydophila pneumoniae; Mycoplasma pneumoniae |
| Faeces | Clostridium difficile toxin B | |
| Genital swabs | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Nasopharyngeal swabs | MecA gene | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bronchoalveolar lavage; Sputum | Mycobacterium tuberculosis complex |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Amniotic fluid; Blood; Plasma; Serum | Parvovirus B19 |
| Amniotic fluid; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Endotrachael aspirate; Plasma; Saliva; Tissues; Urine; Vesicle fluid; Vitreous specimens | Cytomegalovirus (CMV) | |
| Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Nasopharyngeal aspirate; Nasopharyngeal swabs; Plasma; Serum | Enterovirus | |
| Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Influenza A virus; Influenza A virus H1; Influenza A virus H3; Influenza A virus H5; Influenza A virus H7 - 2013 China strain; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Cerebrospinal fluid (CSF); Plasma; Tissues; Urine | John Cunningham virus (JC) | |
| BK virus | ||
| Cerebrospinal fluid (CSF); Vesicle fluid; Vitreous specimens | Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Faeces | Norovirus | |
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Human metapneumovirus | |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | ||
| Plasma | Hepatitis C virus (HCV) viral RNA | |
| Cytomegalovirus (CMV) | ||
| Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Hepatitis C virus (HCV) genotypes 1-6 and subtypes | ||
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Other body fluids; Respiratory specimens; Sputum; Tissues | Mycobacteria identification |
| Urine | Mycobacteria identification | |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Hair; Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements | Blood; Cerebrospinal fluid (CSF); Fluids; Genital swabs; Ocular specimens; Respiratory swabs; Tissues; Urine | Fungi identification; Yeasts identification |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Skin scrapings | Scabies | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cerebrospinal fluid (CSF); Serum | Anti-streptolysin O (ASOT) |
| Syphilis Treponema pallidum antibody | ||
| Serum | Cytomegalovirus antibody (anti-CMV) IgG; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Rubella IgM antibody | |
| Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody | ||
| Brucella spp. | ||
| Measles IgG antibody; Mumps virus IgG antibody; Varicella zoster virus IgG antibody | ||
| Measles IgM antibody; Mumps virus IgM antibody | ||
| Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies | ||
| Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen | ||
| Syphilis Treponema pallidum antibody | ||
| Mycoplasma pneumoniae | ||
| Hepatitis B virus surface antigen (HBs Ag) | ||
| Human immunodeficiency virus (HIV) subtype O; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies | ||
| Human T-lymphotropic virus type I (HTLV-I) | ||
| Hepatitis E virus (HEV) IgM | ||
| Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody | ||
| Herpes simplex virus (HSV) IgG | ||
| Epstein-Barr virus early antigen IgA antibody; Epstein-Barr virus viral capsid antigen IgA antibody | ||
| Microbiology - Virology - Detection of pathogenic viruses | Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Tracheal aspirate | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV) |
| Eye swabs; Nasopharyngeal aspirate | Chlamydia trachomatis | |
| Faeces | Rotavirus |
POCT Unit – Accident and Emergency
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Carboxyhaemoglobin; Chloride; Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
POCT Unit – Intensive Care Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Carboxyhaemoglobin; Chloride; Lactate; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
POCT Unit – Neonatal Intensive Care Unit
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Carboxyhaemoglobin; Chloride; Methaemoglobin (MetHb); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
POCT Unit – ObGyn Department
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Chloride; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
POCT Unit – Operating Theatre
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Calcium - Ionised; Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
POCT Unit – Shatin Hospital
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Chloride; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
POCT Unit – Wards
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Blood glucose |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
14149
Site No.
14142
Print date
23 May 2022
END OF SCOPE